Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2025-12-24 @ 9:36 PM
NCT ID: NCT02715232
Eligibility Criteria: Inclusion Criteria: * DSM-5 diagnosis of Gender Dysphoria (DSM-5: 302.85; ICD-10: F64.1) (for transsexuals only) * Somatic health based on history, physical examination, ECG, laboratory screening, SCID * willingness and competence to sign the informed consent form Exclusion Criteria: * concomitant major medical or neurological illness * internal or neurologic medical histories as well as pregnancy (positive urine pregnancy test) or breastfeeding * other DSM-5 Axis-I comorbidities, determined by a structured clinical interview (SCID), especially body dysphoric disorder (DSM-5: 300.7; ICD-10: F45.22), schizophrenia spectrum and other psychotic disorders * steroid hormone treatment within 6 months prior to inclusion * treatment with psychotropic agents such as SSRIs * any implant or stainless steel graft * abnormal values in routine laboratory screening or general physical examination * current substance abuse or current or past substance related disorder * for participants who participated in an earlier neuroimaging study using ionizing radiation, the total radiation exposure dose of 20 mSv over the last 10 years must not be exceeded, as specified in the legislation on radiation protection (Allg. Strahlenschutzverordnung 2010; www.ris.bka.gv.at) * failure to comply with the study protocol or to follow the instructions of the investigating team
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 50 Years
Study: NCT02715232
Study Brief:
Protocol Section: NCT02715232